氟哌噻吨美利曲辛辅助治疗质子泵抑制剂治疗无效的非糜烂性反流病

目的观察氟哌噻吨美利曲辛（黛力新）辅助治疗质子泵抑制剂治疗无效的非糜烂性反流病（NERD）的疗效。方法58例患者随机分为两组，对照组29例予口服埃索美拉唑40mg，1次／d；治疗组29例予口服埃索美拉唑40mg，1次／d，加口服氟哌噻吨美利曲辛1片，1次／d，治疗4周后进行疗效对比及汉密顿焦虑量表（HAMA）评分。结果治疗组与对照组的总有效率分别为93．1％、62．07％，治疗组的疗效优于对照组（P〈0．01）。治疗后治疗组HAMA评分为11．62±2．86明显优于对照组20．91±2．14（P〈0．01）。结论氟哌噻吨美利曲辛辅助埃索美拉唑对质子泵抑制剂治疗无效的非糜烂性反流病有效，且能显著改善患者的焦虑症状。

Deanxit in adjuvant treatment of non-erosive reflux disease non-responding to proton pump inhibitor

Objective To investigate the efficacy of flupentixol and melitracen(Deanxit) in treatment of non-erosive reflux disease(NERD) and non-responding to proton pump inhibitor. Methods Fifty eight NERD pa-tients were randomly divided into two groups, the treatment group (n = 29) and control group (n = 29). Patients in control group were given esomeprazole 40 mg qd. Patients in the treatment group were given the same drug plus Deanxit 1 Tab qd. The clinical effect was evaluated and scored by Hemihon Anxiety Rating Scale (HAMA) after 4 weeks. Results The total efficacy rate of the treatment group was higher than control group (P < 0.01),and HAMA was lower in the treatment group than in control group (P < 0.01). Conclusions Adjuvant treatment of Deanxit combined with esomeprazole is effective to NERD patients who did not respond to proton pump inhibitor, can greatly improve anxious disorders.